FDA Allows BioMedomics’ SARS-CoV-2 Serology Tests for Diagnostic Use
The covid-19 antibody test works in 15 minutes, and features an intuitive visual interpretation. No special equipment is needed.
Read MoreSearch Results for: point-of-care
Sight Diagnostics’ Olo Deployed in Israeli Hospital to Help Support Coronavirus Quarantine Measures
Olo, a compact blood analyzer from Sight Diagnostics, Tel Aviv, Israel, has been installed in Sheba Tel Hashomer’s special quarantined lab to support the management of coronavirus patients.
Read More
Procise CRP Assay Receives CE Mark
The Procise CRP assay fits the company’s strategy of developing and commercializing 2- to 5-minute point-of-care tests that are easy, immediate, and accurate.
Read More
MBio Diagnostics, SRI Partner for BARDA Contracts
MBio partners with SRI International on diagnostic programs funded by BARDA.
Read MoreMesa Biotech Developing Molecular Point-of-Care Diagnostic Test for COVID-19
Building upon the existing Accula molecular platform, Mesa’s coronavirus test aims to deliver accurate and accessible testing close to the patient, providing critical information to healthcare providers in China, the United States, and other affected countries
Read More